HAL (France)open access
Impact of geriatric covariates on metronomic cyclophosphamide efficacy and tolerance—the CHEMETROLD study
Geriatric oncology, 0, Frailty, Advanced cancer, 1, Cyclophosphamide, Metronomic chemotherapy cyclophosphamide advanced cancer geriatric oncology frailty Implications, Metronomic chemotherapy
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 643243
Conceptio Open Knowledge Archive — every document is proof-bundled with source, license, and retrieval metadata.